baber/WOPTO huggingface dataset:
Patent NZ-503130-A (NZ)
Title: Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
Inventor: CLARKE GEOFFREY DUKE EDWARD
IPC: A61P17/00
Filed: 1998-09-07
Abstract: The compounds of formula (I) may be used in the treatment of inflammatory disorders of the respiratory tract. In compound (I); R1 is C1-6 alkyl; R2 is C2-4 alkyl or C2-4 alkenyl; X represents CO or SO2; Het represents an optionally substituted 5-10 membered monocyclic or bicyclic aromatic ring system containing 1 to 4 heteroatoms selected from O, N and S; n represents an integer 0 to 4; R3 and R4 independently represent H, C1-8 alkyl, (CH2)1-4CONR5R6, COC1-4alkyl or (CH2)0-2Ph, where Ph represents phenyl optionally substituted by one or more C1-4alkyl or halogen groups; or NR3R4 together represents azetidinyl, pyrrolidinyl, piperidinyl, azepinyl, morpholinyl, piperazinyl optionally N-substituted by C1-6 alkyl, phenyl (optionally substituted by halogen or C1-4alkyl) or benzyl (optionally substituted on the benzene ring by halogen or C1-4alkyl), or NR3R4 together represent a ring as just described save that it is substituted on carbon by one or more C1-4 alkyl, CONR5, R6 or COOR6 groups; and R5 and R6 independently represent H or C1-4 alkyl.
Patent NZ-506376-A (NZ)
Title: Carrier for cans has container openings with transverse straight sides
Inventor: MARCO LESLIE S
IPC: B65D71/50
Filed: 2000-08-16
Abstract: Provided is a carrier for containers, such as drinking cans, which comprises a planar, preferably plastics, sheet formed with a plurality of container openings configured to allow an integral panel to remain in tight and flat position (Figure 2) or a contoured and tight position with respect to the containers (Figure 9).
Patent NZ-506511-A (NZ)
Title: Controller for roller door, uses encoder wheel to determine door position
Inventor: KINSEY COLIN JOHN
IPC: E05F15/20
Filed: 2000-08-23
Abstract: A controller for a garage door of the roller type includes a ring gear 1 which is used to drive the door.  A follower gear 5, which is driven from the ring gear, drives a position wheel 3 and cutter wheel 4.  The position gear has a series of  arcuate projections of different radii on its underside, which may encode a 3 bit gray code.  The movement of the projections as the position wheel rotates is detected by opto-interrupters, and this can be related to the position of the door.  The speed of the door is detected by cutter wheel 4 as teeth on the wheel pass an optical sensor.  Output from the position wheel and cutter wheel is used to control the door so that it stops at the limits of its travel, and will stop if door movement is prevented by an obstruction.
Patent NZ-507680-A (NZ)
Title: Immunomodulators and carriers for immunogenic peptides comprising multiple repeats of muramyl dipeptide
Inventor: GELDER FRANK B
IPC: C07K17/10
Filed: 1997-10-10
Abstract: Described is an immunomodulator including a polymer or copolymer of glycopeptide(s) extensively cross-linked and in the form of macroparticles.  The glycopeptide(s) include multiple repeats of muramyl dipeptide.  The multiple repeats of muramyl dipeptide include a terminal dipeptide of L-alanine-D-isoglutamide.
Patent NZ-508388-A (NZ)
Title: Artemisinine derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
Inventor: LI YING
IPC: A61P35/00
Filed: 1999-06-09
Abstract: Described are compounds of the formula (I), wherein; R represents the radical of formula (II), A represents a group of formula (III), wherein R1 represents an aryl, substituted aryl, heteroaryl or substituted heteroaryl group, R2 represents a hydrogen atom or a substituted or unsubstituted linear or branched C1-6alkyl group, or A represents a group of formula (IV), wherein Y represents a substituted or unsubstituted linear or branched C2-14alkylene, substituted or unsubstituted linear or branched C2-14alkenylene, substituted or unsubstituted linear or branched C2-14alkynylene, phenylene, substituted phenylene, naphthylene or substituted napthylene group, Z represents an oxygen or sulfur atom, or a group NR,2 wherein R,2 has the same meaning as R2, and R3 represents a group of formula (III).
Patent NZ-508749-A (NZ)
Title: Agents for combating plant pests containing imidacloprid [1-(6-chloro-3-pyridylmethyl)-2-nitroiminoimidazolidine]
Inventor: MAULER-MACHNIK ASTRID
IPC: A01N47/44
Filed: 1999-05-29
Abstract: A composition for controlling plant pests which contain the compound of the formula shown in a mixture with fungicidally active compounds, except for cyclopropylcarboxamide derivatives and azolmethylcycloalkanes. The composition contain in a synergically effective amounts selected from tebucanazole, propiconazole, difenconazole, cyproconazoleflutriafol, hexaconazole, myclobutanil, penconazole, furconazole, etaconazole, bromuconazole, fenbuconazole, tetraconazole, tridimenol, tridimefon, diclobutrazole, diniconazole, flusilazolefluquinconazole, tridemorph, aldimorph, fenpropimorph, fenpropidin, pyrifenox or vinclozolin.
Patent NZ-513520-A (NZ)
Title: Improvements in or relating to scissors
Inventor: JANES KIERAN CRAIG
IPC: D03D49/70
Filed: 2001-08-14
Abstract: A cutting device such as scissors comprises a pair of pivotally connected members. The members include cutting blades and handles, and each handle has a gripping member. One gripping member is a thumb member. The distances from the pivot to the point of connection between the thumb member and the remainder of the handle to which the member is connected is greater than the distance between the pivot and the center of the thumb member. The thumb member is mounted on the remainder of the handle through adjustment means which enable the distance between the gripping members to the selected and the rotational orientation of the thumb member to the selected relative to the remainder of the cutting device. The adjustment means also allow the thumb member to be fixed in the selection position.
Patent NZ-514877-A (NZ)
Title: Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
Inventor: SOUTH MICHAEL S
IPC: C07D239/545
Filed: 2000-05-18
Abstract: Substituted polycyclic aryl and heteroaryl uracil compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases are disclosed.
Patent NZ-514976-A (NZ)
Title: A spray control device
Inventor: OOSTERMAN MICHAEL HENRY AART
IPC: B05B12/00
Filed: 2000-06-02
Abstract: A spray control device for use with vehicle mountable spraying apparatus having a pump (11) for conveying fluid under pressure to a spray head (B). The control device has a pressure sensor (10) for sensing the pressure of the fluid near the spray head (B). A speed sensor enables calculation of vehicle speed. An adjustment device (24) adjusts the delivery of fluid to the spray head (B). A microprocessor (14) is programmed to calculate from information derived from the pressure sensor (10) and speed sensor spray application rate. The microprocessor (14) compares the application rate with a stored target application rate to thereby cause the adjustment device (24) to, if necessary, adjust the pump (12) so that the pressure of fluid delivery achieves the target application rate.
Patent NZ-523421-A (NZ)
Title: Anthelminthic agents for the prevention of parasitic infections in humans and animals
Inventor: HARDER ACHIM
IPC: A61K31/445
Filed: 2001-06-25
Abstract: Disclosed is the use of compounds of formula (I) for the preparation of compositions for deterring helmintic parasites, wherein: Y is H, optionally substituted alkyl or O-X, X is H, COR11, COOR12 or R13, R1 is optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl or cycloalkenyl, R2, R11, R12 and R13 are independently optionally substituted alkyl or alkenyl, R3-R10 are independently H or optionally substituted alkyl, or R2 and R3, or R3 and R7, or R3 and R5, or R5 and R7 may together form an optionally substituted monocyclic ring, n and m are independently 0 or 1. Also disclosed is a method for deterring helmintic parasites, wherein the compounds of formula (I) are applied to the skin of the organism to be protected.
Patent NZ-525693-A (NZ)
Title: Improvements relating to billboards
Inventor: BREGMEN JASON
IPC: G09F19/14
Filed: 2003-05-06
Abstract: An apparatus for displaying images includes an enclosure (11), a frame (20) installed in the enclosure and adapted to hold an interlaced image (21), and an optical barrier (12) comprising a plurality of substantially parallel elongated grills spaced from the frame and adapted to obscure portions of an installed interlaced image. The interlaced image in conjunction with the optical barrier displays 3D images to a viewer.
Patent NZ-528045-A (NZ)
Title: Method and kit for diagnosing GH deficiency
Inventor: RANKE MICHAEL
IPC: C12Q1/6883
Filed: 2002-04-30
Abstract: A method and kit for diagnosis of autosomal dominantly inherited isolated growth hormone deficiency (IGHD II) that comprises in vitro analyzing the presence or absence of the missense mutation G6191 to T in exon 4 of GH-I which changes valine 110 to phenylalanine.
Patent NZ-535972-A (NZ)
Title: Formulation comprising buprenorphine
Inventor: BIRCH PHILLIP JOHN
IPC: A61K31/407
Filed: 2003-03-19
Abstract: Disclosed is an aqueous solution suitable for intranasal administration which comprises from 0.1 to 10 mg/ml of buprenorphine or a physiologically acceptable salt or ester thereof and from 5 to 40 mg/ml of a pectin having a degree of esterification of less than 50%; which solution has a pH of from 3 to 4.2, is substantially free from divalent metal ions and gels on the nasal mucosa.
Patent NZ-537005-A (NZ)
Title: Animal feed composition comprising mucosa byproduct
Inventor: VAN DE LIGT CHRISTIAAN P A
IPC: A23K1/10
Filed: 2003-06-18
Abstract: Animal feeds, which include compositions utilizing mucosa byproducts derived from mucosal material, such as digested gut material, are provided. The feeds can include a mucosa byproduct which contains at least about 10 wt.% nucleic acid material; at least about 20 wt.% mucopolysaccharides; and no more than about 10 wt.% proteinaceous material. The mucosa byproduct is produced by a process which includes digesting animal mucosal material to form a mucosal digest; and separating the mucosal digest to provide (a) a protein-enriched stream and (b) a polyanionic-enriched stream, which includes mucopolysaccharides and nucleic acid material.
Patent NZ-538571-A (NZ)
Title: Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
Inventor: CEVC GREGOR
IPC: A61K31/5415
Filed: 2003-10-09
Abstract: The specification describes combinations of at least three amphipatic substances forming aggregate suspensions in a polar liquid. Judicious choice of system components, which differ at least 2-times to 10-times in solubility, ensures said aggregates to have extended, unusually adaptable surfaces. This is probably due to simultaneous action on said aggregates of at least two more soluble substances amongst said three system components, at least one of which is an active ingredient and preferably a drug; the third component, alternatively, can take the role of a drug. The specification further deals with the use of said combinations in pharmaceutical preparations capable of transporting drugs into the body of warm blood creatures. This is made possible by the drug loading capability of said aggregates with the highly flexible and deformable coating, which renders the resulting drug carriers highly adaptable. The specification finally reveals suitable methods and favourable conditions for carrier manufacturing and application. The specification also describes novel formulations of nonsteroidal anti-inflammatory drugs (NSAIDs) based on complex aggregates with at least three amphipatic components suspended in a suitable, e.g. pharmaceutically acceptable, polar liquid medium. Particularly disclosed is a preparation based on a combination of at least one first (membrane forming component MFC), at least one second (membrane destabilising component MDC), and at least one third (membrane destabilising component MDC) amphipatic component suspended in a suitable liquid medium in the form of corresponding mixed amphipat aggregates with extended surface(ESAs) with one or a few mixed amphipat coating(s), wherein said ESAs formed by a combination of all three said components have surfaces in contact with said liquid medium that are at least 50% more extended, on the average, than the typical surfaces of aggregates comprising the said at least one second and at least one third amphipatic component alone, at the same concentrations and, in case, after adjustment for the physico-chemical effects of resulting from the absence of said first amphipatic compound (MFC) for application, administration or transport of an active ingredient, which can be one of the three amphipatic components, especially for biological, medical, immunological, or cosmetic purposes, into and through the pores in semi-permeable barriers or other constrictions, such as through the skin of warm blood creatures or the like.
Patent NZ-542021-A (NZ)
Title: Electromagnetic wave absorptive film and it's fabrication
Inventor: YEN LI-HSIEN
Filed: 2005-08-25
Abstract: An electromagnetic wave absorption film and a method of fabrication the film is disclosed, wherein the film comprises: a compound layer, said compound layer having a plurality of grains embedded therein, a thickness equal to (1/4)n times of the wavelength of the electromagnetic wave to be destructively interfered, wherein n is natural number; and a reflective layer covering one side of said compound layer, said reflective layer having a refractive index greater than said compound layer, whereby all of the electromagnetic waves incident on the reflective layer are reflected back into said compound layer to be scattered by said grains, absorbed, and to combine in a destructive fashion with incident electromagnetic waves so as to reduce re-emission of the incident electromagnetic waves from said absorptive film.
Patent NZ-542220-A (NZ)
Title: Antibody against the tumor specific antigen oculospanin
Inventor: ICHIKAWA KIMIHISA
IPC: C12N15/12
Filed: 2004-03-09
Abstract: Disclosed is an antibody that binds specifically to human oculospanin and has cytotoxic activity against a cell expressing that protein. Also described is a method of detecting cancer wherein the expression of human oculospanin gene is used as an index and a pharmaceutical composition comprising the human oculospanin antibody.
Patent NZ-544936-A (NZ)
Title: Preparation of metal salts of medium-chain fatty acids
Inventor: DUCEPPE JEAN-SIMON
IPC: C07C51/41
Filed: 2004-07-23
Abstract: Disclosed is a method of preparing a metal salt of a medium-chain fatty acid, wherein the method comprises solubilising at least one free fatty acid in a solvent that comprises an alcohol, wherein said free fatty acid has a chain length from six to twelve carbons, and reacting said free fatty acid with at least one metal bicarbonate or at least one metal carbonate, to produce a metal fatty acid salt.
Patent NZ-546623-A (NZ)
Title: Golf grip system
Inventor: MCCREE NEIL
Filed: 2006-04-18
Abstract: A golf glove and grip system, and method for assisting a golfer to correctly position their hands are disclosed. A golf glove has a marking (210) on the thumb portion that in use is aligned with a marking on a golf club grip to indicate a correct top hand thumb position. Further embodiments include additional markings for further aligning the golfer's hands on the grip.
Patent NZ-552525-A (NZ)
Title: Resealable closures
Inventor: VON SPRECKELSEN HENNING
IPC: B65D55/06
Filed: 2005-07-27
Abstract: A closure comprising a spout and an overcap adapted to be sealed to a container neck by means of a double-sided foil is provided. The overcap has a depending valve which sealingly engages with the spout to hold these components together prior to assembly to the container. The spout has a flange covered by the foil and adapted to seat on a rim of the container neck, and an annular wall that is received within the container neck such that the flange is the only part of the spout above the rim. A ridge surrounds the annular wall of the spout to retain an annulus of foil. A method of assembling a closure is also provided.
Patent NZ-552667-A (NZ)
Title: Therapeutic and diagnostic agents
Inventor: MANNERING STUART IAN
Filed: 2005-07-22
Abstract: Disclosed is an isolated peptide comprising an amino acid sequence from a non-full length A-chain of proinsulin or insulin and having two cysteine residues which form an intra-chain disulfide bond with each other which peptide activates proinsulin- or insulin-sensitive CD4+ T-cells said peptide consisting of the amino acid sequence given in any one of SEQ ID NOs: 10, 22, 23, 26, 27, 32, 34 or 35 or a homolog of said peptide.
Patent NZ-553328-A (NZ)
Title: Humanized anti-beta7 antagonists and uses therefor
Inventor: DENNIS MARK S
IPC: C07K16/18
Filed: 2005-09-02
Abstract: Provided is an anti-beta7 antibody comprising an HVR-L1 sequence RASESVDDLLH and specified sequences for the other CDRs. Further provided are variants of the antibody and uses of it in vitro and in the manufacture of medicaments for various inflammatory diseases.
Patent NZ-554315-A (NZ)
Title: A milk conveyer device
Inventor: JOHANNESSON LEIF BORJE
IPC: G01N33/04
Filed: 2007-04-04
Abstract: A milk conveyer device (100) including functionality for analysing a characteristic of milk is disclosed. The milk conveyer device is to be implemented in a milking arrangement which comprises a milk storage reservoir (101) coupled to a milking attachment for attaching to an animal to be milked through a main milk conduit (103, 105). A sample element (107, 109) extracts milk, which is collected in a sample reservoir (115, 117) which is in turn connected to an analysis element (129) through an analysis conduit (123, 125). During the flow of the milk from the sample reservoir to the analysis element, the milk itself provides a cleaning effect. The flow is initially at a high flow rate and later at a reduced flow rate. A plurality of analysis conduits are connected to the analysis element, which comprises a selector unit (127), which couples milk from one of the analysis conduits to the analysis element. The device provides a self-cleaning effect and a low carry-over of milk between the two successive milking operations, i.e. between the milk of two different animals.
Patent NZ-561699-A (NZ)
Title: Process for removing color bodies from hydrocarbon-based fuels using activated carbon
Inventor: JOSEPH JOSEPH T
IPC: C10G25/00
Filed: 2006-03-30
Abstract: Disclosed is a process for removing colour bodies from hydrocarbon-based fuel comprising the steps of: a) contacting hydrocarbon-based fuel with a decolorizing carbon having within its pore structure a fuel decolorizing amount of reduced transition metal in the range of from about 0.1% to about 5%; and b) adsorbing at least a portion of colour bodies selected from the group consisting of indanes, naphthalenes, phenanthrenes, pyrene, alkylbenzenes, and mixtures thereof within the hydrocarbon-based fuel onto the decolorizing carbon to produce a decolorized hydrocarbon-based fuel.
Patent NZ-567334-A (NZ)
Title: Production of oligodendrocytes from placenta-derived stem cells
Inventor: HEIDARAN MOHAMMAD
IPC: C12N5/079
Filed: 2006-10-13
Abstract: Disclosed is a method of producing an oligodendrocyte, comprising culturing a placental stem cell under conditions and for a time sufficient for said stem cell to exhibit a characteristic of an oligodendrocyte, wherein said placental stem cell is not a human totipotent cell or trophoblast, wherein said culturing comprises contacting said stem cell with isobutylmethylxanthine (IBMX); and wherein said characteristic is the production of myelin oligodendrocyte specific protein (MOSP) or expression of a gene encoding MOSP.
Patent NZ-572186-A (NZ)
Title: N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
Inventor: RAMAKRISHNA VENKATA SATYA NIROGI
IPC: A61P25/00
Filed: 2003-06-05
Abstract: Disclosed is a process for the preparation of N-arylsulfonyl-3-substituted indole compounds of formula (I), wherein the substituents are as defined in the specification, their tautomeric forms, stereoisomers, geometric forms, N-oxides, polymorphs and pharmaceutical formulations. Also disclosed are the compounds prepared by the above process. The compounds are useful for treatment of mental disorders, migraines, hypertension sleep disorders. (62) Divided Out of 540840
Patent NZ-575364-A (NZ)
Title: Method for producing prepregs
Inventor: STAABS BURKHARD
IPC: C08J5/04
Filed: 2007-02-28
Abstract: A method for producing prepregs 10 consisting of synthetic resin and reinforcement fibers with defined contours. First structural fiber elements 16 consisting of at least one layer of reinforcement fibers are produced with contours corresponding to the contours of the prepregs 10 to be produced. Next the structural fiber elements 16 are placed on a carrier net 12 and are saturated with a resin which is then partially cured. Finally the prepregs 10 obtained together with the areas of the carrier net respectively covered by them, are separated from the portion of the carrier net surrounding them.
Patent NZ-579627-A (NZ)
Title: Stabilization of vitamin b12 using butanol
Inventor: HEEP IRIS
IPC: A61K31/66
Filed: 2008-03-07
Abstract: Disclosed is a preparation comprising vitamin B12, n-butanol, and butaphosphan and the use of n-butanol to stabilise vitamin B12.
Patent NZ-581009-A (NZ)
Title: Closure system for a ostomy drainable pouch
Inventor: TSAI MINGLIANG LAWRENCE
IPC: A61F5/44
Filed: 2008-04-23
Abstract: Disclosed is a drainable ostomy pouch (10) having a closure system that includes a resealable press and seal material. The pouch is formed from front and rear panels joined along their edges. The pouch has an outlet in its tail portion (22) and the front panel has a stomal opening (16) for receiving waste. The tail portion includes a closure system with textured film which is coated with self-sealing adhesive on at least one of said panels located proximate to the outlet. The film is foldable upon itself so as to resealably close the outlet. The film covers at least one panel of the tail portion entirely.
Patent NZ-581875-A (NZ)
Title: Bed mounted invalid exercise machine using two pair of cranks to move all of a persons limbs together
Inventor: THORN CLEMENT STEPHEN VICTOR
IPC: A61H99/00
Filed: 2009-12-14
Abstract: A bed mounted invalid exercise machine (1) is disclosed. The machine (1) allows an invalid to exercise, move and offset discomfort of limbs that are subject to lack of body movement. The machine (1) includes: a) a frame having a base (2) , a central column (3) and two side arms (4) b) a first crank (7) with handles (71), attached within the central column c) a second crank (6) with a pair of pedals (61), attached to and within the central column d) a drive means situated within the central column and e) a support (43) attachable to the side arms (4) wherein the support means (43) is adapted to support and hold the invalid in position whilst using said exercising machine (1). The central column (3) is pivotally connected to the base (2) and, the side arms (4) are attached at the base (2) to support the machine on the bed surface. The drive means connects the two cranks (6, 7) so that one may move the other. In this way an invalid with movement in their arms may move their legs if attached to the pedals (61) and vice-versa.